- Report
- August 2023
- 104 Pages
Europe
From €3090EUR$3,450USD£2,712GBP
- Report
- August 2023
- 97 Pages
North America
From €2642EUR$2,950USD£2,319GBP
- Report
- August 2023
- 83 Pages
Africa, Middle East
From €2642EUR$2,950USD£2,319GBP
- Report
- August 2023
- 106 Pages
Global
From €2642EUR$2,950USD£2,319GBP
- Report
- November 2024
- 120 Pages
Global
From €3500EUR$4,186USD£3,179GBP
- Report
- November 2024
- 90 Pages
Global
From €3500EUR$4,186USD£3,179GBP
- Book
- March 2018
- 328 Pages
- Book
- October 2017
- 340 Pages
- Book
- February 2017
- 236 Pages
- Report
- March 2025
- 473 Pages
Global
From €2378EUR$2,655USD£2,087GBP
- Book
- October 2023
Global

Zoonosis is a term used to describe the transmission of infectious diseases between animals and humans. Infectious disease testing is an important tool in the diagnosis and management of zoonotic diseases. Tests can be used to detect the presence of a pathogen, identify the species of the pathogen, and determine the level of infection. Tests can also be used to monitor the effectiveness of treatments and to assess the risk of transmission from animals to humans.
Infectious disease testing for zoonotic diseases is a growing market, with a range of products and services available. Companies offer tests for a variety of pathogens, including bacteria, viruses, fungi, and parasites. Tests can be performed in a laboratory or in the field, and can be used to detect the presence of a pathogen in a sample or to monitor the effectiveness of treatments.
Companies in the zoonosis market include Bio-Rad Laboratories, Cepheid, Hologic, Luminex, Qiagen, and Thermo Fisher Scientific. Show Less Read more